Vyne Therapeutics Inc VYNE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:22 AM EDT
2.71quote price arrow down-0.05 (-1.81%)
Volume
8,213
52 week range
1.67 - 7.72
Loading...
  • Open2.84
  • Day High2.84
  • Day Low2.67
  • Prev Close2.76
  • 52 Week High7.72
  • 52 Week High Date05/23/23
  • 52 Week Low1.67
  • 52 Week Low Date01/31/24

Key Stats

  • Market Cap39.373M
  • Shares Out14.53M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change16.31

KEY STATS

  • Open2.84
  • Day High2.84
  • Day Low2.67
  • Prev Close2.76
  • 52 Week High7.72
  • 52 Week High Date05/23/23
  • 52 Week Low1.67
  • 52 Week Low Date01/31/24
  • Market Cap39.373M
  • Shares Out14.53M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change16.31

RATIOS/PROFITABILITY

  • EPS (TTM)-5.26
  • P/E (TTM)-0.51
  • Fwd P/E (NTM)-3.13
  • EBITDA (TTM)-30.764M
  • ROE (TTM)-51.92%
  • Revenue (TTM)423,000.008
  • Gross Margin (TTM)50.27%
  • Net Margin (TTM)-6,738.06%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vyne Therapeutics Inc

 

Profile

MORE
VYNE Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing differentiated therapies for the treatment of immuno-inflammatory conditions. Its product candidate is VYN201, a locally administered pan-BET inhibitor designed as a soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways while providing low systemic exposure. Its second program is VYN202, a BD2-selective oral small molecule bromodomain and...
David Domzalski
President, Chief Executive Officer, Director
Tyler Zeronda
Chief Financial Officer, Treasurer
Mutya Harsch J.D.
Chief Legal Officer, General Counsel, Secretary
Address
685 Route 202/206 N., Suite 301
Bridgewater, NJ
08807
United States

Top Peers

SYMBOLLASTCHG%CHG
CYTH
Cyclo Therapeutics Inc
1.35-0.08-5.59%
TXMD
TherapeuticsMD Inc
2.07-0.02-1.11%
KALA
KALA BIO Inc
6.75-0.01-0.09%
SEEL
Seelos Therapeutics Inc
2.22-0.10-4.44%
TLPH
Talphera Inc
1.16-0.06-4.94%